| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 68.0% | 65.7% | ▼ -2.3% |
| Healthcare Services | 13.6% | 19.0% | ▲ +5.4% |
| Food Products | 2.6% | 2.7% | ● +0.1% |
| Industrial Products | 0.5% | 2.2% | ▲ +1.8% |
| Chemicals & Petrochemicals | 0.5% | 2.1% | ▲ +1.7% |
| Insurance | 1.1% | 2.0% | ▲ +1.0% |
| Retailing | 1.2% | 1.4% | ▲ +0.2% |
| Aerospace & Defense | 0.0% | 0.6% | ▲ +0.6% |
| Agricultural Food & other Products | 1.2% | 0.0% | ▼ -1.2% |
| Diversified FMCG | 2.2% | 0.0% | ▼ -2.2% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 65.7% | 66.3% | ▲ +0.6% |
| Healthcare Services | 19.0% | 19.3% | ▲ +0.2% |
| Food Products | 2.7% | 2.8% | ▲ +0.2% |
| Chemicals & Petrochemicals | 2.1% | 2.2% | ● +0.0% |
| Industrial Products | 2.2% | 2.0% | ▼ -0.2% |
| Retailing | 1.4% | 1.2% | ▼ -0.2% |
| Insurance | 2.0% | 1.0% | ▼ -1.0% |
| Financial Technology (Fintech) | 0.0% | 1.0% | ▲ +1.0% |
| Aerospace & Defense | 0.6% | 0.3% | ▼ -0.3% |
Comparing May 2026 → Jun 2026
| # | Stock | Sector | Weight (Jun 2026) |
|---|---|---|---|
| 1 | Turtlemint Fintech Solutions Limited ₹3.55 Cr |
Financial Technology (Fintech) | 1.00% |
| # | Stock | Sector | Last Weight (May 2026) |
|---|---|---|---|
| 1 | ICICI Prudential Life Insurance Company Limited ₹3.02 Cr |
Insurance | 0.91% |
| # | Stock | Sector | May 2026 | Jun 2026 | Change |
|---|---|---|---|---|---|
| 1 | Rubicon Research Limited ₹21.32 Cr |
Pharmaceuticals & Biotechnology | 4.52% | 6.02% | +1.50% |
| 2 | Max Healthcare Institute Limited ₹14.72 Cr |
Healthcare Services | 3.68% | 4.16% | +0.48% |
| 3 | Aurobindo Pharma Limited ₹23.07 Cr |
Pharmaceuticals & Biotechnology | 6.17% | 6.52% | +0.35% |
| 4 | Senores Pharmaceuticals Ltd ₹8.11 Cr |
Pharmaceuticals & Biotechnology | 2.05% | 2.29% | +0.24% |
| 5 | Neuland Laboratories Limited ₹16.24 Cr |
Pharmaceuticals & Biotechnology | 4.39% | 4.59% | +0.20% |
| 6 | Emcure Pharmaceuticals Limited ₹15.43 Cr |
Pharmaceuticals & Biotechnology | 4.18% | 4.36% | +0.18% |
| 7 | Zydus Wellness Limited ₹9.98 Cr |
Food Products | 2.65% | 2.82% | +0.17% |
| 8 | IPCA Laboratories Limited ₹8.59 Cr |
Pharmaceuticals & Biotechnology | 2.31% | 2.43% | +0.12% |
| 9 | Laurus Labs Limited ₹7.59 Cr |
Pharmaceuticals & Biotechnology | 2.05% | 2.14% | +0.09% |
| 10 | GlaxoSmithKline Pharmaceuticals Limited ₹5.83 Cr |
Pharmaceuticals & Biotechnology | 1.58% | 1.65% | +0.07% |
| # | Stock | Sector | May 2026 | Jun 2026 | Change |
|---|---|---|---|---|---|
| 1 | Divi's Laboratories Limited ₹29.75 Cr |
Pharmaceuticals & Biotechnology | 9.07% | 8.40% | -0.67% |
| 2 | Piramal Pharma Limited ₹21.38 Cr |
Pharmaceuticals & Biotechnology | 6.51% | 6.04% | -0.47% |
| 3 | MTAR Technologies Limited ₹1.14 Cr |
Aerospace & Defense | 0.59% | 0.32% | -0.27% |
| 4 | MedPlus Health Services Limited ₹4.19 Cr |
Retailing | 1.39% | 1.18% | -0.21% |
| 5 | Shaily Engineering Plastics Ltd ₹7.18 Cr |
Industrial Products | 2.23% | 2.03% | -0.20% |
| 6 | Sun Pharmaceutical Industries Limited ₹22.50 Cr |
Pharmaceuticals & Biotechnology | 6.54% | 6.36% | -0.18% |
| 7 | Glenmark Pharmaceuticals Limited ₹6.12 Cr |
Pharmaceuticals & Biotechnology | 1.90% | 1.73% | -0.17% |
| 8 | Abbott India Limited ₹4.42 Cr |
Pharmaceuticals & Biotechnology | 1.40% | 1.25% | -0.15% |
| 9 | Biocon Limited ₹4.79 Cr |
Pharmaceuticals & Biotechnology | 1.48% | 1.35% | -0.13% |
| 10 | Fortis Healthcare Limited ₹11.50 Cr |
Healthcare Services | 3.36% | 3.25% | -0.11% |
33 stocks — Jun 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹29.75 Cr |
Pharmaceuticals & Biotechnology |
8.40%
|
|
| 2 |
₹23.75 Cr |
Healthcare Services |
6.71%
|
|
| 3 |
₹23.07 Cr |
Pharmaceuticals & Biotechnology |
6.52%
|
|
| 4 |
₹22.50 Cr |
Pharmaceuticals & Biotechnology |
6.36%
|
|
| 5 |
₹21.38 Cr |
Pharmaceuticals & Biotechnology |
6.04%
|
|
| 6 |
₹21.32 Cr |
Pharmaceuticals & Biotechnology |
6.02%
|
|
| 7 |
₹18.63 Cr |
Pharmaceuticals & Biotechnology |
5.26%
|
|
| 8 |
₹16.24 Cr |
Pharmaceuticals & Biotechnology |
4.59%
|
|
| 9 |
₹15.43 Cr |
Pharmaceuticals & Biotechnology |
4.36%
|
|
| 10 |
₹14.72 Cr |
Healthcare Services |
4.16%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.